Different associations of adipokines in lean and healthy adults

Hormone and Metabolic Research

Volumn 46, Issue 1, 2014, Pages 41-47

  Ebert, T ^a,b   Roth, I ^a   Richter, J ^a,b   Tonjes A ^a,b   Kralisch, S ^a,b   Lossner, U ^a,b   Kratzsch, J ^a   Bluher M ^a   Stumvoll, M ^a   Fasshauer, M ^a,b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

adipokines; leanness; metabolism

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; CHEMERIN; FATTY ACID BINDING PROTEIN 4; FIBROBLAST GROWTH FACTOR 21; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; RESISTIN; RETINOL BINDING PROTEIN 4; TRIACYLGLYCEROL;

ADIPOCYTE; ADULT; AGE; ARTICLE; BASAL METABOLIC RATE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; EATING DISORDER; ENZYME LINKED IMMUNOSORBENT ASSAY; FAT MASS; FEMALE; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; KIDNEY FUNCTION; LEAN BODY WEIGHT; LIPID METABOLISM; MALE; MIDDLE AGED; NORMAL HUMAN; OBESITY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; WAIST HIP RATIO; WAIST TO HEIGHT RATIO;

ADIPOKINES; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEALTH; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; REGRESSION ANALYSIS; STATISTICS, NONPARAMETRIC; THINNESS;

EID: 84892525964     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0033-1353198     Document Type: Article

References (39)

1. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun: 1999; 257 79 83
2. Cnop M., Havel P. J., Utzschneider K. M., Carr D. B., Sinha M. K., Boyko E. J., Retzlaff B. M., Knopp R. H., Brunzell J. D., Kahn S. E. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia: 2003; 46 459 469
3. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J. M. Positional cloning of the mouse obese gene and its human homologue. Nature: 1994; 372 425 432
4. Halaas J. L., Gajiwala K. S., Maffei M., Cohen S. L., Chait B. T., Rabinowitz D., Lallone R. L., Burley S. K., Friedman J. M. Weight-Reducing Effects of the Plasma-Protein Encoded by the Obese Gene. Science: 1995; 269 543 546
5. Considine R. V., Sinha M. K., Heiman M. L., Kriauciunas A., Stephens T. W., Nyce M. R., Ohannesian J. P., Marco C. C., McKee L. J., Bauer T. L., Caro J. F. Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese Humans. N Engl J Med: 1996; 334 292 295
6. Maffei M., Halaas J., Ravussin E., Pratley R. E., Lee G. H., Zhang Y., Fei H., Kim S., Lallone R., Ranganathan S. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med: 1995; 1 1155 1161
7. Xu A., Wang Y., Xu J. Y., Stejskal D., Tam S., Zhang J., Wat NM S., Wong W. K., Lam KS L. Adipocyte Fatty Acid - Binding Protein Is a Plasma Biomarker Closely Associated with Obesity and Metabolic Syndrome. Clin Chem: 2006; 52 405 413
8. Bozaoglu K., Bolton K., McMillan J., Zimmet P., Jowett J., Collier G., Walder K., Segal D. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology: 2007; 148 4687 4694
9. Goralski K. B., McCarthy T. C., Hanniman E. A., Zabel B. A., Butcher E. C., Parlee S. D., Muruganandan S., Sinal C. J. Chemerin, a Novel Adipokine That Regulates Adipogenesis and Adipocyte Metabolism. J Biol Chem: 2007; 282 28175 28188
10. Lehrke M., Becker A., Greif M., Stark R., Laubender R. P., von Ziegler F., Lebherz C., Tittus J., Reiser M., Becker C., Goke B., Leber A. W., Parhofer K. G., Broedl U. C. Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. Eur J Endocrinol: 2009; 161 339 344
11. Nishimura T., Nakatake Y., Konishi M., Itoh N. Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim Biophys Acta: 2000; 1492 203 206
12. Zhang X., Yeung DC Y., Karpisek M., Stejskal D., Zhou Z-G, Liu F., Wong RL C., Chow W-S, Tso AW K., Lam KS L., Xu A. Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans. Diabetes: 2008; 57 1246 1253
13. Steppan C. M., Bailey S. T., Bhat S., Brown E. J., Banerjee R. R., Wright C. M., Patel H. R., Ahima R. S., Lazar M. A. The hormone resistin links obesity to diabetes. Nature: 2001; 409 307 312
14. Heilbronn L. K., Rood J., Janderova L., Albu J. B., Kelley D. E., Ravussin E., Smith S. R. Relationship between Serum Resistin Concentrations and Insulin Resistance in Nonobese, Obese, and Obese Diabetic Subjects. JCEM: 2004; 89 1844 1848
15. Shetty G. K., Economides P. A., Horton E. S., Mantzoros C. S., Veves A. Circulating Adiponectin and Resistin Levels in Relation to Metabolic Factors, Inflammatory Markers, and Vascular Reactivity in Diabetic Patients and Subjects at Risk for Diabetes. Diabetes Care: 2004; 27 2450 2457
16. Reilly M. P., Lehrke M., Wolfe M. L., Rohatgi A., Lazar M. A., Rader D. J. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation: 2005; 111 932 939
17. Graham T. E., Yang Q., Blüher M., Hammarstedt A., Ciaraldi T. P., Henry R. R., Wason C. J., Oberbach A., Jansson P-A, Smith U., Kahn B. B. Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects. N Engl J Med: 2006; 354 2552 2563
18. Paul T., Thiel A. Eating Disorder Inventory-2 (EDI-2): deutsche Version. Göttingen Hogrefe: 2005
19. Matthews D. R., Hosker J. P., Rudenski A. S., Naylor B. A., Treacher D. F., Turner R. C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia: 1985; 28 412 419
20. Levey A. S., Stevens L. A., Schmid C. H., Zhang Y. L., Castro A. F., Feldman H. I., Kusek J. W., Eggers P., Van Lente F., Greene T., Coresh J. A New Equation to Estimate Glomerular Filtration Rate. Ann Intern Med: 2009; 150 604 612
21. Savage D. B., Sewter C. P., Klenk E. S., Segal D. G., Vidal-Puig A., Considine R. V., O'Rahilly S. Resistin/Fizz3 Expression in Relation to Obesity and Peroxisome Proliferator - Activated Receptor-g Action in Humans. Diabetes: 2001; 50 2199 2202
22. Silha J. V., Krsek M., Skrha J. V., Sucharda P., Nyomba B. L., Murphy L. J. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol: 2003; 149 331 335
23. Tönjes A., Fasshauer M., Kratzsch J., Stumvoll M., Blüher M. Adipokine Pattern in Subjects with Impaired Fasting Glucose and Impaired Glucose Tolerance in Comparison to Normal Glucose Tolerance and Diabetes. PLoS One [Internet]: 2010; [cited 2013 Jan 21]; 5 Available from http://www.ncbi.nlm.nih. gov/pmc/articles/PMC2976690/
24. Yannakoulia M., Yiannakouris N., Bluher S., Matalas A. L., Klimis-Zacas D., Mantzoros C. S. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab: 2003; 88 1730 1736
25. Tönjes A., Kralisch S., Lössner U., Kovacs P., Blüher M., Stumvoll M., Fasshauer M. Metabolic and genetic predictors of circulating adipocyte fatty acid-binding protein. Inter J Obes: 2012; 36 766 773
26. Koh S. B., Yoon J., Kim J. Y., Yoo B. S., Lee S. H., Park J. K., Choe K. H. Relationships between Serum Adiponectin with Metabolic Syndrome and Components of Metabolic Syndrome in Non-Diabetic Koreans: ARIRANG Study. Yonsei Med J: 2011; 52 234 241
27. Miller G. D., Frost R., Olive J. Relation of plasma leptin concentrations to sex, body fat, dietary intake, and peak oxygen uptake in young adult women and men. Nutrition: 2001; 17 105 111
28. Finucane F. M., Luan J., Wareham N. J., Sharp S. J., O'Rahilly S., Balkau B., Flyvbjerg A., Walker M., Hojlund K., Nolan J. J., Savage D. B. Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia: 2009; 52 2345 2349
29. Kralisch S., Stepan H., Kratzsch J., Verlohren M., Verlohren H-J, Drynda K., Lössner U., Blüher M., Stumvoll M., Fasshauer M. Serum levels of adipocyte fatty acid binding protein are increased in gestational diabetes mellitus. Eur J Endocrinol: 2009; 160 33 38
30. Sommer G., Ziegelmeier M., Bachmann A., Kralisch S., Lossner U., Kratzsch J., Bluher M., Stumvoll M., Fasshauer M. Serum levels of adipocyte fatty acid binding protein are increased in chronic haemodialysis. Clin Endocrinol (Oxf): 2008; 69 901 905
31. Xu A., Tso AW K., Cheung BM Y., Wang Y., Wat NM S., Fong CH Y., Yeung DC Y., Janus E. D., Sham P. C., Lam KS L. Circulating Adipocyte - Fatty Acid Binding Protein Levels Predict the Development of the Metabolic Syndrome A 5-Year Prospective Study. Circulation: 2007; 115 1537 1543
32. Terra X., Quintero Y., Auguet T., Porras J. A., Hernández M., Sabench F., Aguilar C., Luna A. M., del Castillo D., Richart C. FABP 4 is associated with inflammatory markers and metabolic syndrome in morbidly obese women. Eur J Endocrinol: 2011; 164 539 547
33. Weigert J., Neumeier M., Wanninger J., Filarsky M., Bauer S., Wiest R., Farkas S., Scherer M. N., Schäffler A., Aslanidis C., Schölmerich J., Buechler C. Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clin Endocrinol: 2010; 72 342 348
34. Zabel B. A., Silverio A. M., Butcher E. C. Chemokine-like receptor 1 expression and chemerin-directed chemotaxis distinguish plasmacytoid from myeloid dendritic cells in human blood. J Immunol: 2005; 174 244 251
35. Zabel B. A., Ohyama T., Zuniga L., Kim J. Y., Johnston B., Allen S. J., Guido D. G., Handel T. M., Butcher E. C. Chemokine-like receptor 1 expression by macrophages in vivo: regulation by TGF-beta and TLR ligands. Exp Hematol: 2006; 34 1106 1114
36. Dostálová I., Kaválková P., Haluzíková D., Lacinová Z., Mráz M., PapeŽová H., Haluzík M. Plasma Concentrations of Fibroblast Growth Factors 19 and 21 in Patients with Anorexia Nervosa. JCEM: 2008; 93 3627 3632
37. Badman M. K., Pissios P., Kennedy A. R., Koukos G., Flier J. S., Maratos-Flier E. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab: 2007; 5 426 437
38. Qin B., Polansky M. M., Anderson R. A. Cinnamon Extract Regulates Plasma Levels of Adipose-derived Factors and Expression of Multiple Genes Related to Carbohydrate Metabolism and Lipogenesis in Adipose Tissue of Fructose-fed Rats. Horm Metab Res: 2010; 42 187 193
39. Park H., Green M. H., Shaffer M. L. Association between serum retinol-binding protein 4 concentrations and clinical indices in subjects with type 2 diabetes: a meta-analysis. J Human Nutr Diet: 2012; 25 300 310